Robust coagulation activation and coagulopathy in mice with experimental acetaminophen-induced liver failure

J Thromb Haemost. 2023 Sep;21(9):2430-2440. doi: 10.1016/j.jtha.2023.03.040. Epub 2023 Apr 11.

Abstract

Background: Patients with acetaminophen (APAP)-induced acute liver failure (ALF) display both hyper- and hypocoagulable changes not necessarily recapitulated by standard hepatotoxic doses of APAP used in mice (eg, 300 mg/kg).

Objectives: We sought to examine coagulation activation in vivo and plasma coagulation potential ex vivo in experimental settings of APAP-induced hepatotoxicity and repair (300-450 mg/kg) and APAP-induced ALF (600 mg/kg) in mice.

Results: APAP-induced ALF was associated with increased plasma thrombin-antithrombin complexes, decreased plasma prothrombin, and a dramatic reduction in plasma fibrinogen compared with lower APAP doses. Hepatic fibrin(ogen) deposits increased independent of APAP dose, whereas plasma fibrin(ogen) degradation products markedly increased in mice with experimental ALF. Early pharmacologic anticoagulation (+2 hours after 600 mg/kg APAP) limited coagulation activation and reduced hepatic necrosis. The marked coagulation activation evident in mice with APAP-induced ALF was associated with a coagulopathy detectable ex vivo in plasma. Specifically, prolongation of the prothrombin time and inhibition of tissue factor-initiated clot formation were evident even after restoration of physiological fibrinogen concentrations. Plasma endogenous thrombin potential was similarly reduced at all APAP doses. Interestingly, in the presence of ample fibrinogen, ∼10 times more thrombin was required to clot plasma from mice with APAP-induced ALF compared with plasma from mice with simple hepatotoxicity.

Conclusion: The results indicate that robust pathologic coagulation cascade activation in vivo and suppressed coagulation ex vivo are evident in mice with APAP-induced ALF. This unique experimental setting may fill an unmet need as a model to uncover mechanistic aspects of the complex coagulopathy of ALF.

Keywords: acute liver failure; coagulation; coagulopathy; mouse model.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, N.I.H., Extramural

MeSH terms

  • Acetaminophen / metabolism
  • Animals
  • Blood Coagulation Disorders* / chemically induced
  • Blood Coagulation Disorders* / metabolism
  • Chemical and Drug Induced Liver Injury* / etiology
  • Chemical and Drug Induced Liver Injury* / pathology
  • Fibrin / metabolism
  • Fibrinogen / metabolism
  • Liver / metabolism
  • Liver Failure* / metabolism
  • Liver Failure* / pathology
  • Mice
  • Mice, Inbred C57BL
  • Thrombin / metabolism

Substances

  • Acetaminophen
  • Thrombin
  • Fibrin
  • Fibrinogen